
Earlier this month, the FDA approved the first ever migraine drug, galcanezumab-gnlm (Emgality, Lilly) indicated to treat cluster headaches.

Earlier this month, the FDA approved the first ever migraine drug, galcanezumab-gnlm (Emgality, Lilly) indicated to treat cluster headaches.

According to a recent study, data collected through a wearable device called the Personal Kinetigraph (PKG) can assist clinicians in recognizing patients with Parkinson disease who may benefit from deep-brain stimulation or other device-assisted therapies.

Results were presented recently at the 79th Scientific Sessions of the American Diabetes Association.

Some states are losing ground in healthcare coverage and most states are being rocked by rising deaths of despair, reports a national scorecard of the nation’s health.

The consensus report was presented at the 79th Scientific Sessions of the American Diabetes Association in San Francisco, California.

A recent study showed that older adults with uncontrolled asthma can benefit from interventions that tailor self-management support to improve various factors that impede asthma control, including those related to psychosocial, health, function, and cognitive barriers.

Diets high in soy are linked with a decreased risk of osteoporotic bone fractures in pre- and perimenopausal survivors of breast cancer.

Both the FDA and the European Medicines Agency (EMA) have accepted applications to review ozanimod, an oral sphingosine 1-phosphate receptor modulator, for the treatment of relapsing forms of multiple sclerosis (MS).

Survival of patients with multiple myeloma has continued to improve as treatments have evolved over time.

CMS has approved Washington state’s proposal for a subscription model to purchase hepatitis C virus (HCV) drugs; the American Medical Association (AMA) voted against a measure that would drop its decades-long stance against single-payer healthcare proposals; Maine has become the eighth state to legalize medically assisted suicide.

In recent years, fatal overdoses from fentanyl have drastically increased across the nation, with the number of deaths nearly doubling each year from 2013 through 2016.

Today marks the second annual International NASH Day created to raise awareness about nonalcoholic steatohepatitis (NASH) and fatty liver disease.

Abstracts presented at the 2019 American Thoracic Society International Conference suggest that participation in clinical trials and 1-on-1 coaching may improve inhaler technique of patients with chronic obstructive pulmonary disease or other respiratory disorders.

The Community Oncology Alliance (COA) has filed its alternative to CMS' Oncology Care Model (OCM) with the Physician-Focused Payment Model Technical Advisory Committee.

The American Medical Association has called for intensified oversight of the pharmacy benefit manager (PBM) industry; the governor of Florida has signed a bill into law that would allow state residents to access cheaper medication through 2 prescription drug importation programs; the Ebola virus has crossed international borders during the second-worst outbreak in history.

While older adults represent a majority of new cancer diagnoses, they are underrepresented in randomized clinical trials.

Geisinger is launching a new study to test if a novel technique can detect flare-ups or exacerbations experienced by patients with chronic obstructive pulmonary disease (COPD) by listening to their voices through their smart phones.

The United States Preventive Services Task Force (USPSTF) has issued 2 recommendation statements including 3 grade A recommendations for the use of pre-exposure prophylaxis (PrEP) for HIV prevention and HIV screening in adults, adolescents, and pregnant women.

Missouri's only abortion clinic will stay open after a state circuit court judge issued a preliminary injunction; the FDA overlooked red flags for esketamine after Janssen provided only limited data about the drug's safety and efficacy; opiod manufacturer Insys has filed for bankruptcy proctection after agreeing to pay $225 million to settle a federal investigation over its marketing of fentanyl.

As increasing attention is paid to the cost of healthcare, there are growing efforts to steer patients toward high-value care. New research published in JAMA Network Open compared teaching hospitals with nonteaching hospitals to determine the total cost for common conditions.

A pair of study abstracts presented at the 2019 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois, supported the efficacy of entrectinib among 2 different groups of patients, including patients with a rare form of lung cancer and pediatric and adolescent patients with solid tumors.

Patients with type 2 diabetes (T2D) who had been using insulin an average of 8 years and had mean glycated hemoglobin (A1C) levels of 8.9% were able to bring their levels down 0.9% after 3 months, according to chart review data from 3 European countries.

In an era when healthcare is extremely expensive, there are many opinions on how involved our federal government should be in bringing drug prices down. However, there is one particular drug-pricing crisis that many can agree needs to be addressed sooner rather than later: the insulin crisis.

Purdue Pharmaceuticals and the company’s owners have been sued by Idaho’s Attorney General for allegedly contributing to the opioid epidemic; the governor of Texas has signed a bill into law that will raise the state’s minimum age to purchase tobacco and tobacco-related products to 21; California law makers have agreed to a budget deal that will provide healthcare to young, low-income, undocumented immigrants.

A recent study found that patients with sickle cell who had more frequent or severe vaso-occlusive crises (VOCs) had greater absenteeism, overall productivity loss, and activity impairment than patients with less frequent or severe VOCs.

Study findings have revealed that survivors of pediatric hematologic malignancies who underwent hematopoietic stem-cell transplantation (HSCT) exhibit quantitative and qualitative mandibular bone impairments.

According to 2 abstracts presented at the 2019 American Society of Clinical Oncology Annual Meeting, multimorbidity, insurance status, and income may affect survival rates of patients with multiple myeloma.

The government taking a backseat has opened the market up to disrupters from outside the healthcare industry.

According to new research, recent advances in acoustic engineering and artificial intelligence have “shown promise” in the identification of respiratory conditions based on sound analysis, which may thus reduce dependence on support services and clinical expertise.

This week, the top managed care news included the American Society of Clinical Oncology discussing drug pricing; community oncologists seeking a delay in taking on downside risk in the Oncology Care Model; CDC finding a drop in new diabetes cases in the United States.

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
